Professor Anthony De Soyza
| Autoimmune conditions and bronchiectasis | 2026 |
|
Professor Anthony De Soyza
| Design and rationale of the AIR-NET trial: a randomised, open-label, multifactorial, multicentre, adaptive platform trial using a range of repurposed anti-inflammatory treatments to improve outcomes in patients with bronchiectasis within the EMBARC clinical research network | 2026 |
|
Professor Anthony De Soyza
| Efficacy and safety of brensocatib in Japanese patients with non-cystic fibrosis bronchiectasis: Analysis of the ASPEN trial | 2026 |
|
Professor Anthony De Soyza
| The Worldwide Puzzle of Bronchiectasis Etiology in Adults | 2026 |
|
Professor Anthony De Soyza
| Aspergillus Serologic Findings and Clinical Outcomes in Patients With Bronchiectasis: Data From the European Bronchiectasis Registry | 2025 |
|
Professor Anthony De Soyza
| Airway total bacterial density, microbiota community composition and relationship with clinical parameters in bronchiectasis | 2025 |
|
Professor Anthony De Soyza
| An Observational, Cross-Sectional Study to Investigate Whether Room Air Ventilators, Used in the Community Setting, Are Colonised by Potential Airborne Pathogens (IPAP Study) | 2025 |
|
Professor Anthony De Soyza
Georgina Wild
Phil Mawson
Dr John Steer
Dr Richard McNally
| Anxiety, depression, physical disease parameters and health-related quality of life in the BronchUK national bronchiectasis cohort | 2025 |
|
Professor Anthony De Soyza
| Bisoprolol for patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS RCT | 2025 |
|
Professor Anthony De Soyza
| Broad Immunomodulatory Effects of the Dipeptidyl Peptidase-1 Inhibitor Brensocatib in Bronchiectasis Data from the Phase 2, Double-Blind, Placebo-controlled WILLOW Trial | 2025 |
|
Professor Anthony De Soyza
| Clinical Burden of People with Symptomatic and Exacerbating COPD While on Triple Inhaled Therapy † | 2025 |
|
Dr Nina Wilson
Tara Homer
Ann Konkoth
Richard Joyce
Anneka Kershaw
et al. | Dual Bronchodilators in Bronchiectasis Study: a randomised controlled trial | 2025 |
|
Dr Joe Kibbler
Professor Anthony De Soyza
| Evaluation of real-world use of pulmonary embolism thrombolysis: Erupt | 2025 |
|
Professor Anthony De Soyza
Gareth Davies
| Hypertonic Saline or Carbocisteine in Bronchiectasis | 2025 |
|
Professor Anthony De Soyza
| Impact of rheumatoid arthritis, seropositivity and disease-modifying anti-rheumatic drugs on mortality risk in bronchiectasis | 2025 |
|
